Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
89 studies found for:    Open Studies | "Osteosarcoma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Mifamurtide arm;   Other: 3 drugs arm
2 Recruiting Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: High Dose Methotrexate
3 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: Sm-EDTMP;   Other: Autologous Stem Cell Infusion;   Radiation: External Beam Radiotherapy
4 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: heavy ion radiotherapy (C12)
5 Recruiting Phase II Trial for the Treatment of Relapsed Osteosarcoma
Condition: OSTEOSARCOMA
Interventions: Drug: Gemcitabine and Docetaxel;   Drug: Ifosfamide
6 Recruiting Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
7 Recruiting Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
Condition: Osteosarcoma
Interventions: Drug: Leucovorin;   Drug: [6R] 5,10-methylenetetrahydrofolate
8 Recruiting Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Drug: Glembatumumab Vedotin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
9 Recruiting Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Biological: humanized anti-GD2 antibody;   Drug: GM-CSF
10 Recruiting Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Conditions: Osteosarcoma;   Metastasis
Intervention: Drug: apatinib
11 Recruiting Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
Condition: Osteosarcoma
Intervention: Biological: Tissue Procurement
12 Recruiting Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Conditions: Childhood Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Denosumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
13 Recruiting Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
Conditions: Solid Tumor;   Osteosarcoma
Intervention: Drug: Sirolimus combined with CP, MT and ZA
14 Recruiting Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Conditions: Osteosarcoma;   Nephrotoxicity;   Ototoxicity
Interventions: Drug: Pantoprazole;   Drug: High-dose methotrexate infusion duration
15 Recruiting Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the Extremity
Condition: High Grade Osteosarcoma
Intervention: Drug: continuous oral cyclophosphamide and methotrexate
16 Recruiting Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Conditions: Metastatic Malignant Neoplasm in the Lung;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Dinutuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Sargramostim
17 Recruiting Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Condition: Sarcoma
Intervention: Other: biologic sample preservation procedure
18 Recruiting Monocyte Phenotypic and Functional Differences
Condition: Osteosarcoma
Intervention: Biological: Blood draw
19 Recruiting Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
Conditions: Tumors;   Solid Malignant Tumors;   Osteosarcoma;   Differentiated Thyroid Cancer (DTC)
Interventions: Drug: Lenvatinib;   Drug: Ifosfamide;   Drug: Etoposide
20 Recruiting SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas
Conditions: Liposarcoma;   Osteogenic Sarcoma;   Ewing/Ewing-like Sarcoma
Interventions: Drug: Regorafenib;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.